<DOC>
	<DOCNO>NCT01722604</DOCNO>
	<brief_summary>The main purpose prospective study demonstrate therapeutic equivalence topical brinzolamide dose three time daily compare AzoptTM ( brinzolamide ophthalmic suspension 1 % ) dose three time daily IOP reduction patient POAG OH .</brief_summary>
	<brief_title>Therapeutic Equivalence Study Generic Brinzolamide v Azopt</brief_title>
	<detailed_description />
	<mesh_term>Ocular Hypertension</mesh_term>
	<mesh_term>Brinzolamide</mesh_term>
	<criteria>Male female 18 year age old , diagnose primary openangle glaucoma ocular hypertension . Patients form glaucoma ( secondary , congenital , juvenile normal tension glaucoma , angle closure glaucoma ) either eye primary openangle glaucoma , ocular hypertension .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>